Showing 3761-3770 of 4063 results for "".
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat
- Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minuteshttps://modernod.com/news/abbott-launches-molecular-point-of-care-test-to-detect-novel-coronavirus-in-as-little-as-five-minutes/2477479/Abbott announced that the FDA has issued Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test for the detection of novel coronavirus (COVID-19), delivering positive results in as little as 5 minutes and negative results in 13 minutes, according to a company new
- Prevent Blindness Releases Message to Eye Care Patients Regarding the COVID-19 Pandemichttps://modernod.com/news/prevent-blindness-releases-message-to-eye-care-patients-regarding-the-covid-19-pandemic/2477470/In response to the numerous queries from patients and caregivers, Prevent Blindness has issued the following statement in regards to eye care during the coronavirus pandemic. “For everyone’s health and s
- COVID-19 Roundtable: How Retina Doctors From Around the United States Are Adjusting Their Clinicshttps://modernod.com/news/covid-19-roundtable-how-retina-doctors-from-around-the-united-states-are-adjusting-their-clinics/2477467/Eyewire News checked in with four retina specialists in COVID-19 hotspots around the United States—Seattle, New York, Boston, and Orlando—to see how they are adjusting their clinics in light of the AAO’s latest guidance. To read a full summary of their adjustments, read the forthcoming April issu
- ASCRS to Host Webinars for Eye Care Professionals Dealing With COVID-19 Outbreakhttps://modernod.com/news/ascrs-to-host-webinars-for-eye-care-professionals-dealing-with-covid-19-outbreak/2477450/The American Society of Cataract and Refractive Surgery (ASCRS) will host two webinars this week for ophthalmologists and eye care professionals to help deal with the manifestations of COVID-19. On Wednesday, March 25, ASCRS will host a complimentary webinar on “Neurotrophic Keratiti
- Iveric Bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officerhttps://modernod.com/news/iveric-bio-appoints-pravin-u-dugel-md-as-executive-vice-president-and-chief-strategy-and-business-officer/2477448/Iveric bio announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer, effective April 1, 2020. In this role, Dr. Dugel will help shape Iveric bio’s business development strategy going forward. Dr. Dugel brings more than 25 years’ experie
- CMS Recommends Limit on Nonessential Planned Surgeries, Including Postponement of Cataract Procedureshttps://modernod.com/news/cms-recommends-limit-on-nonessential-planned-surgeries-including-postponement-of-cataract-procedures/2477414/On March 18, CMS issued a series of recommendations regarding the furnishing of all nonessential planned surgeries and procedures based on the need to conserve critical resources, such as ventilators and personal protective equipment, and limiting exposure of patients and staff to COVID-19, accor
- AAO Provides Updated COVID-19 Guidance for Outpatient Clinics and Elective Surgeryhttps://modernod.com/news/aao-provides-updated-guidance-for-outpatient-clinics-and-elective-surgery/2477395/In response to the state of national emergency declared at the federal level, particularly as COVID-19 progresses in a given community, ophthalmologists should seriously consider both the intensity of clinic scheduling and the issue of elective surgeries, particularly in elderly patients and thos
- Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEOhttps://modernod.com/news/second-sight-announces-departure-of-will-mcguire-president-and-ceo-and-appointment-of-gregg-williams-as-acting-ceo/2477384/Second Sight Medical Products announced the departure of Will McGuire, President and Chief Executive Officer, effective March 27, 2020, to pursue another professional opportunity located closer to his family. Mr. McGuire remains as a director on Second Sight’s board. Effective March 27, 20
- Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officerhttps://modernod.com/news/clearside-biomedical-appoints-dr-george-lasezkay-as-president-and-chief-executive-officer/2477375/Clearside Biomedical announced that George Lasezkay, Pharm.D., JD, has been appointed President and Chief Executive Officer. He will continue to serve on the Board of Directors. This appointment was effective March 1, 2020. “Clearside has made meaningful pro